Tech Company Financing Transactions

Navitor Pharmaceuticals Funding Round

Atlas Venture, Polaris Partners and private investors joined a $23.5 million capital raise for Navitor Pharmaceuticals. The financing round was announced on 3/31/2015.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1030 Massachusetts Ave. 410
Cambridge, MA 02138
USA

Phone

(781) 258-6153

Website

www.navitorpharma.com

Email Address

[email protected]

Overview

New scientific insights are emerging regarding the primal signaling pathways that direct an organism's metabolic response to conditions in its environment--such as dynamic changes in the availability of nutrients, energy, oxygen and other factors--and the role of these metabolic signaling pathways in disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Thomas Hughes

        

Chief Medical Officer

James Owen

        

VP - Bus. Development

Rick Lundberg

        

VP - R & D

Eddine Saiah

        

Browse more venture capital transactions:

Prev: 3/31/2015: Cytrellis Biosystems venture capital transaction
Next: 3/31/2015: CalStar Products venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary